Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.75 USD | +3.87% | +7.66% | +154.31% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,214 | 505.6 | 301.7 | 770.5 | - | - |
Enterprise Value (EV) 1 | 936.9 | 339.7 | 79.02 | 533.3 | 505.4 | 458.2 |
P/E ratio | -111 x | -22.5 x | -8.53 x | -18.8 x | -12.6 x | -11.9 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - |
EV / EBITDA | -62.1 x | -11.1 x | - | -11.5 x | -6.94 x | -4.59 x |
EV / FCF | -60.9 x | -12.9 x | - | -14 x | -8.56 x | -3.98 x |
FCF Yield | -1.64% | -7.73% | - | -7.12% | -11.7% | -25.1% |
Price to Book | 4.38 x | 2.02 x | 1.39 x | 2.84 x | 3.98 x | 3.04 x |
Nbr of stocks (in thousands) | 52,021 | 52,021 | 52,021 | 52,028 | - | - |
Reference price 2 | 23.33 | 9.720 | 5.800 | 14.81 | 14.81 | 14.81 |
Announcement Date | 3/28/22 | 3/2/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - |
EBITDA 1 | - | -15.08 | -30.51 | - | -46.3 | -72.85 | -99.75 |
EBIT 1 | - | -15.1 | -30.55 | -41.22 | -46.5 | -76.15 | -86.6 |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -9.202 | -22.46 | -35.59 | -40.83 | -74.15 | -83.47 |
Net income 1 | -0.446 | -9.202 | -22.46 | -35.59 | -42.78 | -72.32 | -83.47 |
Net margin | - | - | - | - | - | - | - |
EPS 2 | -0.0150 | -0.2110 | -0.4320 | -0.6800 | -0.7875 | -1.176 | -1.247 |
Free Cash Flow 1 | - | -15.39 | -26.27 | - | -38 | -59.07 | -115.2 |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 6/4/21 | 3/28/22 | 3/2/23 | 2/29/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA 1 | -6.612 | -7.995 | -6.739 | -6.614 | -9.159 | -10.34 | -9.845 | -9.639 | - | -11.45 | -11.35 | -11.55 | -11.95 | - | - |
EBIT 1 | -6.621 | -8.006 | -6.75 | -6.626 | -9.172 | -10.42 | -9.925 | -9.719 | -11.16 | -11.53 | -11.73 | -11.77 | -11.47 | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -4.091 | -5.763 | 0.334 | -0.441 | -16.59 | -10.94 | -7.729 | -5.649 | -11.27 | -7.666 | -11.27 | -11.17 | -10.73 | - | - |
Net income 1 | -4.091 | -5.763 | 0.334 | -0.441 | -16.59 | -10.94 | -7.729 | -5.649 | -11.27 | -7.666 | -11.27 | -11.17 | -10.73 | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.0860 | -0.1110 | 0.006000 | -0.008000 | -0.3190 | -0.2100 | -0.1500 | -0.1100 | -0.2100 | -0.1500 | -0.2200 | -0.2200 | -0.2050 | -0.2100 | -0.2200 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/28/22 | 5/18/22 | 8/23/22 | 11/10/22 | 3/2/23 | 5/11/23 | 8/23/23 | 11/9/23 | 2/29/24 | 5/3/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - |
Net Cash position 1 | - | 277 | 166 | 223 | 237 | 265 | 312 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | -15.4 | -26.3 | - | -38 | -59.1 | -115 |
ROE (net income / shareholders' equity) | - | -3.28% | -8.52% | -15.2% | -15.4% | -32.3% | -39.8% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share 2 | - | 5.330 | 4.800 | 4.180 | 5.210 | 3.720 | 4.870 |
Cash Flow per Share 2 | - | -0.3500 | -0.5000 | - | -0.5700 | -0.3900 | -1.410 |
Capex 1 | - | 0.1 | 0.07 | 1.07 | 2.05 | 2.17 | 3.7 |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 6/4/21 | 3/28/22 | 3/2/23 | 2/29/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+154.31% | 739M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- GHRS Stock
- Financials GH Research PLC